CN101427796A - Liquid milk with additive algae docosatetraenoic acid suitable for baby of 0 to 6 months old - Google Patents
Liquid milk with additive algae docosatetraenoic acid suitable for baby of 0 to 6 months old Download PDFInfo
- Publication number
- CN101427796A CN101427796A CNA2008101835154A CN200810183515A CN101427796A CN 101427796 A CN101427796 A CN 101427796A CN A2008101835154 A CNA2008101835154 A CN A2008101835154A CN 200810183515 A CN200810183515 A CN 200810183515A CN 101427796 A CN101427796 A CN 101427796A
- Authority
- CN
- China
- Prior art keywords
- milk
- vitamin
- added
- whey protein
- dha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013336 milk Nutrition 0.000 title claims abstract description 85
- 239000008267 milk Substances 0.000 title claims abstract description 85
- 210000004080 milk Anatomy 0.000 title claims abstract description 85
- 239000007788 liquid Substances 0.000 title claims abstract description 45
- 241000195493 Cryptophyta Species 0.000 title claims abstract description 20
- FPRKGXIOSIUDSE-SYACGTDESA-N (2z,4z,6z,8z)-docosa-2,4,6,8-tetraenoic acid Chemical compound CCCCCCCCCCCCC\C=C/C=C\C=C/C=C\C(O)=O FPRKGXIOSIUDSE-SYACGTDESA-N 0.000 title abstract description 44
- 235000021292 Docosatetraenoic acid Nutrition 0.000 title abstract description 38
- 239000000654 additive Substances 0.000 title 1
- 230000000996 additive effect Effects 0.000 title 1
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 115
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 113
- 239000000843 powder Substances 0.000 claims abstract description 83
- 235000021119 whey protein Nutrition 0.000 claims abstract description 69
- 239000005862 Whey Substances 0.000 claims abstract description 46
- 229940088594 vitamin Drugs 0.000 claims abstract description 46
- 229930003231 vitamin Natural products 0.000 claims abstract description 46
- 235000013343 vitamin Nutrition 0.000 claims abstract description 46
- 239000011782 vitamin Substances 0.000 claims abstract description 46
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 38
- 239000011707 mineral Substances 0.000 claims abstract description 38
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 27
- 239000008101 lactose Substances 0.000 claims abstract description 25
- 239000003381 stabilizer Substances 0.000 claims abstract description 25
- 235000019871 vegetable fat Nutrition 0.000 claims abstract description 18
- 238000002360 preparation method Methods 0.000 claims abstract description 17
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 16
- 239000000047 product Substances 0.000 claims description 49
- 235000013350 formula milk Nutrition 0.000 claims description 39
- 239000000126 substance Substances 0.000 claims description 39
- 230000001954 sterilising effect Effects 0.000 claims description 38
- 235000010755 mineral Nutrition 0.000 claims description 37
- -1 stachyose tetrasaccharide Chemical class 0.000 claims description 33
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 28
- 235000020256 human milk Nutrition 0.000 claims description 28
- 210000004251 human milk Anatomy 0.000 claims description 28
- 150000001875 compounds Chemical class 0.000 claims description 27
- 239000000463 material Substances 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 22
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 20
- 235000020185 raw untreated milk Nutrition 0.000 claims description 19
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 18
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 18
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 18
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 18
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 18
- 239000011575 calcium Substances 0.000 claims description 18
- 229960005069 calcium Drugs 0.000 claims description 18
- 229910052791 calcium Inorganic materials 0.000 claims description 18
- 235000001465 calcium Nutrition 0.000 claims description 18
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 18
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 16
- 239000011777 magnesium Substances 0.000 claims description 16
- 229910052749 magnesium Inorganic materials 0.000 claims description 16
- 229940091250 magnesium supplement Drugs 0.000 claims description 16
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 15
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 15
- 229910052802 copper Inorganic materials 0.000 claims description 15
- 239000010949 copper Substances 0.000 claims description 15
- 239000000839 emulsion Substances 0.000 claims description 15
- 238000001816 cooling Methods 0.000 claims description 14
- 229910052742 iron Inorganic materials 0.000 claims description 14
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 13
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 13
- 229910052748 manganese Inorganic materials 0.000 claims description 13
- 239000011572 manganese Substances 0.000 claims description 13
- 239000011701 zinc Substances 0.000 claims description 13
- 229910052725 zinc Inorganic materials 0.000 claims description 13
- 241000196324 Embryophyta Species 0.000 claims description 12
- 239000012467 final product Substances 0.000 claims description 12
- 238000001694 spray drying Methods 0.000 claims description 12
- 238000012859 sterile filling Methods 0.000 claims description 12
- 150000003904 phospholipids Chemical class 0.000 claims description 11
- 235000018102 proteins Nutrition 0.000 claims description 11
- 102000004169 proteins and genes Human genes 0.000 claims description 11
- 108090000623 proteins and genes Proteins 0.000 claims description 11
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 10
- 229930003268 Vitamin C Natural products 0.000 claims description 10
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 10
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 10
- 235000019154 vitamin C Nutrition 0.000 claims description 10
- 239000011718 vitamin C Substances 0.000 claims description 10
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 9
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 9
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 9
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 9
- 229930003427 Vitamin E Natural products 0.000 claims description 9
- 229930003448 Vitamin K Natural products 0.000 claims description 9
- 229960002685 biotin Drugs 0.000 claims description 9
- 235000020958 biotin Nutrition 0.000 claims description 9
- 239000011616 biotin Substances 0.000 claims description 9
- 239000002131 composite material Substances 0.000 claims description 9
- 238000001704 evaporation Methods 0.000 claims description 9
- 229960000304 folic acid Drugs 0.000 claims description 9
- 235000019152 folic acid Nutrition 0.000 claims description 9
- 239000011724 folic acid Substances 0.000 claims description 9
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 9
- 235000001968 nicotinic acid Nutrition 0.000 claims description 9
- 229960003512 nicotinic acid Drugs 0.000 claims description 9
- 239000011664 nicotinic acid Substances 0.000 claims description 9
- 229940055726 pantothenic acid Drugs 0.000 claims description 9
- 235000019161 pantothenic acid Nutrition 0.000 claims description 9
- 239000011713 pantothenic acid Substances 0.000 claims description 9
- 239000011574 phosphorus Substances 0.000 claims description 9
- 229910052698 phosphorus Inorganic materials 0.000 claims description 9
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 9
- 239000011591 potassium Substances 0.000 claims description 9
- 229910052700 potassium Inorganic materials 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 9
- 239000011734 sodium Substances 0.000 claims description 9
- 229910052708 sodium Inorganic materials 0.000 claims description 9
- 239000011691 vitamin B1 Substances 0.000 claims description 9
- 239000011715 vitamin B12 Substances 0.000 claims description 9
- 239000011647 vitamin D3 Substances 0.000 claims description 9
- 235000019165 vitamin E Nutrition 0.000 claims description 9
- 239000011709 vitamin E Substances 0.000 claims description 9
- 229940046009 vitamin E Drugs 0.000 claims description 9
- 235000019168 vitamin K Nutrition 0.000 claims description 9
- 239000011712 vitamin K Substances 0.000 claims description 9
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 9
- 229940046010 vitamin k Drugs 0.000 claims description 9
- 239000005018 casein Substances 0.000 claims description 8
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 8
- 235000021240 caseins Nutrition 0.000 claims description 8
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 8
- 239000000194 fatty acid Substances 0.000 claims description 8
- 229930195729 fatty acid Natural products 0.000 claims description 8
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 8
- 239000011726 vitamin B6 Substances 0.000 claims description 8
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 7
- 229920000161 Locust bean gum Polymers 0.000 claims description 7
- 229930006000 Sucrose Natural products 0.000 claims description 7
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 7
- 239000000679 carrageenan Substances 0.000 claims description 7
- 235000010418 carrageenan Nutrition 0.000 claims description 7
- 229920001525 carrageenan Polymers 0.000 claims description 7
- 229940113118 carrageenan Drugs 0.000 claims description 7
- 235000020778 linoleic acid Nutrition 0.000 claims description 7
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 7
- 229960004488 linolenic acid Drugs 0.000 claims description 7
- 239000000711 locust bean gum Substances 0.000 claims description 7
- 235000010420 locust bean gum Nutrition 0.000 claims description 7
- 239000005720 sucrose Substances 0.000 claims description 7
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 7
- 229920002907 Guar gum Polymers 0.000 claims description 6
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 claims description 6
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 claims description 6
- 230000008020 evaporation Effects 0.000 claims description 6
- 239000000665 guar gum Substances 0.000 claims description 6
- 235000010417 guar gum Nutrition 0.000 claims description 6
- 229960002154 guar gum Drugs 0.000 claims description 6
- 239000012528 membrane Substances 0.000 claims description 6
- 229920001542 oligosaccharide Polymers 0.000 claims description 6
- 150000002482 oligosaccharides Chemical class 0.000 claims description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 6
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 claims description 6
- 125000005457 triglyceride group Chemical group 0.000 claims description 6
- 235000012000 cholesterol Nutrition 0.000 claims description 5
- 239000011248 coating agent Substances 0.000 claims description 5
- 238000000576 coating method Methods 0.000 claims description 5
- 235000021323 fish oil Nutrition 0.000 claims description 5
- 231100000614 poison Toxicity 0.000 claims description 5
- 239000003440 toxic substance Substances 0.000 claims description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 4
- 239000004368 Modified starch Substances 0.000 claims description 4
- 229920000881 Modified starch Polymers 0.000 claims description 4
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims description 4
- 150000001720 carbohydrates Chemical class 0.000 claims description 4
- 235000014633 carbohydrates Nutrition 0.000 claims description 4
- 235000005687 corn oil Nutrition 0.000 claims description 4
- 239000002285 corn oil Substances 0.000 claims description 4
- 235000012041 food component Nutrition 0.000 claims description 4
- 229930182830 galactose Natural products 0.000 claims description 4
- 235000019426 modified starch Nutrition 0.000 claims description 4
- 235000012424 soybean oil Nutrition 0.000 claims description 4
- 239000003549 soybean oil Substances 0.000 claims description 4
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims description 4
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 claims description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 3
- 239000005913 Maltodextrin Substances 0.000 claims description 3
- 229920002774 Maltodextrin Polymers 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- 229910052740 iodine Inorganic materials 0.000 claims description 3
- 239000011630 iodine Substances 0.000 claims description 3
- 229940035034 maltodextrin Drugs 0.000 claims description 3
- 238000007670 refining Methods 0.000 claims description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 2
- 244000298479 Cichorium intybus Species 0.000 claims description 2
- DKKCQDROTDCQOR-UHFFFAOYSA-L Ferrous lactate Chemical compound [Fe+2].CC(O)C([O-])=O.CC(O)C([O-])=O DKKCQDROTDCQOR-UHFFFAOYSA-L 0.000 claims description 2
- 229930091371 Fructose Natural products 0.000 claims description 2
- 239000005715 Fructose Substances 0.000 claims description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 244000068988 Glycine max Species 0.000 claims description 2
- 235000010469 Glycine max Nutrition 0.000 claims description 2
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 2
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 claims description 2
- FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 2
- 235000010216 calcium carbonate Nutrition 0.000 claims description 2
- 239000001110 calcium chloride Substances 0.000 claims description 2
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 2
- 235000011148 calcium chloride Nutrition 0.000 claims description 2
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 claims description 2
- 239000001354 calcium citrate Substances 0.000 claims description 2
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims description 2
- 239000001527 calcium lactate Substances 0.000 claims description 2
- 235000011086 calcium lactate Nutrition 0.000 claims description 2
- 229960002401 calcium lactate Drugs 0.000 claims description 2
- 239000001506 calcium phosphate Substances 0.000 claims description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 2
- 235000011010 calcium phosphates Nutrition 0.000 claims description 2
- 229910000365 copper sulfate Inorganic materials 0.000 claims description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 2
- 229960002413 ferric citrate Drugs 0.000 claims description 2
- 239000011706 ferric diphosphate Substances 0.000 claims description 2
- 235000007144 ferric diphosphate Nutrition 0.000 claims description 2
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 claims description 2
- 229940036404 ferric pyrophosphate Drugs 0.000 claims description 2
- 239000004222 ferrous gluconate Substances 0.000 claims description 2
- 235000013924 ferrous gluconate Nutrition 0.000 claims description 2
- 229960001645 ferrous gluconate Drugs 0.000 claims description 2
- 239000004225 ferrous lactate Substances 0.000 claims description 2
- 235000013925 ferrous lactate Nutrition 0.000 claims description 2
- 229940037907 ferrous lactate Drugs 0.000 claims description 2
- 229960001781 ferrous sulfate Drugs 0.000 claims description 2
- 239000011790 ferrous sulphate Substances 0.000 claims description 2
- 235000003891 ferrous sulphate Nutrition 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 229960003284 iron Drugs 0.000 claims description 2
- 229940082629 iron antianemic preparations Drugs 0.000 claims description 2
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 claims description 2
- 229910000359 iron(II) sulfate Inorganic materials 0.000 claims description 2
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 claims description 2
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 claims description 2
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 2
- 235000011147 magnesium chloride Nutrition 0.000 claims description 2
- 239000004337 magnesium citrate Substances 0.000 claims description 2
- 235000002538 magnesium citrate Nutrition 0.000 claims description 2
- 229960005336 magnesium citrate Drugs 0.000 claims description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 2
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 2
- 229940099596 manganese sulfate Drugs 0.000 claims description 2
- 239000011702 manganese sulphate Substances 0.000 claims description 2
- 235000007079 manganese sulphate Nutrition 0.000 claims description 2
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 2
- 229940067631 phospholipid Drugs 0.000 claims description 2
- 230000000087 stabilizing effect Effects 0.000 claims description 2
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 2
- 235000013337 tricalcium citrate Nutrition 0.000 claims description 2
- PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 claims description 2
- 150000004043 trisaccharides Chemical class 0.000 claims description 2
- 239000011592 zinc chloride Substances 0.000 claims description 2
- 235000005074 zinc chloride Nutrition 0.000 claims description 2
- 229960001939 zinc chloride Drugs 0.000 claims description 2
- 239000011670 zinc gluconate Substances 0.000 claims description 2
- 235000011478 zinc gluconate Nutrition 0.000 claims description 2
- 229960000306 zinc gluconate Drugs 0.000 claims description 2
- 239000011576 zinc lactate Substances 0.000 claims description 2
- 235000000193 zinc lactate Nutrition 0.000 claims description 2
- 229940050168 zinc lactate Drugs 0.000 claims description 2
- 229940120347 zinc preparations Drugs 0.000 claims description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 2
- 229960001763 zinc sulfate Drugs 0.000 claims description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 2
- 239000003344 environmental pollutant Substances 0.000 claims 1
- 231100000719 pollutant Toxicity 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 37
- 238000011161 development Methods 0.000 abstract description 16
- 239000004615 ingredient Substances 0.000 abstract description 11
- 235000020247 cow milk Nutrition 0.000 abstract description 8
- 239000012141 concentrate Substances 0.000 abstract description 6
- 235000013365 dairy product Nutrition 0.000 abstract description 3
- 230000037208 balanced nutrition Effects 0.000 abstract description 2
- 235000019046 balanced nutrition Nutrition 0.000 abstract description 2
- 238000002156 mixing Methods 0.000 description 58
- 238000004659 sterilization and disinfection Methods 0.000 description 39
- 235000019197 fats Nutrition 0.000 description 13
- 230000008901 benefit Effects 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 11
- 238000003756 stirring Methods 0.000 description 11
- 235000008939 whole milk Nutrition 0.000 description 11
- 239000003242 anti bacterial agent Substances 0.000 description 10
- 229940088710 antibiotic agent Drugs 0.000 description 10
- 238000004140 cleaning Methods 0.000 description 10
- 239000007787 solid Substances 0.000 description 10
- 239000000203 mixture Substances 0.000 description 9
- 235000020122 reconstituted milk Nutrition 0.000 description 8
- 230000005484 gravity Effects 0.000 description 7
- 235000021243 milk fat Nutrition 0.000 description 7
- 235000016709 nutrition Nutrition 0.000 description 7
- 238000004806 packaging method and process Methods 0.000 description 7
- 210000000481 breast Anatomy 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 238000001556 precipitation Methods 0.000 description 6
- 235000020183 skimmed milk Nutrition 0.000 description 6
- 230000001502 supplementing effect Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 229910002651 NO3 Inorganic materials 0.000 description 5
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 5
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- 235000019647 acidic taste Nutrition 0.000 description 5
- 239000003513 alkali Substances 0.000 description 5
- 235000014121 butter Nutrition 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 210000000981 epithelium Anatomy 0.000 description 5
- 235000013861 fat-free Nutrition 0.000 description 5
- 239000012535 impurity Substances 0.000 description 5
- 210000000265 leukocyte Anatomy 0.000 description 5
- 235000020191 long-life milk Nutrition 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 239000000447 pesticide residue Substances 0.000 description 5
- 238000005086 pumping Methods 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 241000282412 Homo Species 0.000 description 4
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 4
- 239000000356 contaminant Substances 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000004945 emulsification Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 238000000108 ultra-filtration Methods 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 102000014171 Milk Proteins Human genes 0.000 description 2
- 108010011756 Milk Proteins Proteins 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 235000021342 arachidonic acid Nutrition 0.000 description 2
- 229940114079 arachidonic acid Drugs 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000010612 desalination reaction Methods 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940090949 docosahexaenoic acid Drugs 0.000 description 2
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002366 mineral element Substances 0.000 description 2
- 235000021049 nutrient content Nutrition 0.000 description 2
- 230000009965 odorless effect Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 101100244345 Dunaliella acidophila DHA1 gene Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 201000010538 Lactose Intolerance Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000031320 Teratogenesis Diseases 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000011362 coarse particle Substances 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000000909 electrodialysis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 230000007674 genetic toxicity Effects 0.000 description 1
- 231100000025 genetic toxicology Toxicity 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000003014 ion exchange membrane Substances 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 150000002506 iron compounds Chemical class 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000006920 protein precipitation Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Landscapes
- Dairy Products (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to milk and a preparation method thereof, in particular to infant liquid milk supplemented with algae-derived docosatetraenoic acid (DHA) suitable for newborn to 6 months babies, which belongs to the technical field of dairy products. The ingredients (in weight ratios) of the infant liquid milk are as follows: 200Kg to 500Kg of cow milk, 1Kg to 10Kg of whey protein concentrate 34 (whey protein content of 33%), 20Kg to 100Kg of desalted whey powder D70 (whey protein content of 12%), 20Kg to 100Kg of vegetable fat powder, 1Kg to 10Kg of lactose, 100g to 500g of vitamin complex, 200g to 600g of complex minerals, 1Kg to 8Kg of stabilizers, 300Kg to 700Kg of water, and 0.1Kg to 1Kg of algae-derived DHA. The infant liquid milk has balanced nutrition and fine and smooth mouthfeel, is easy to absorb, and can meet the needs for normal growth and development of infants and simultaneously promote the intelligence development of infants.
Description
Technical Field
The invention relates to milk and a preparation method thereof, in particular to infant liquid milk supplemented with algae DHA (docosatetraenoic acid) suitable for newborn to 6 months babies. Belongs to the technical field of dairy products.
Background
The infant stage is a period of great significance in human life, and breast milk is undoubtedly the most ideal natural food for infants. However, breast milk is not ideal for work, occupation, disease, etc. According to the related data, the breast-feeding rate of infants from birth to six months in China is shown as follows: the city is about 20 percent, and the countryside is about 60 percent. At present, the infant milk replacer in the market of China has limited varieties and incomplete nutritional ingredients, so that the production of reasonable infant milk replacers suitable for the growth and development of infants is urgent.
For infants, the best food is breast milk, which contains nutrients necessary for infant growth and ingredients to enhance the infant's immunity. However, in society today, many lactating women often fail to provide adequate breast milk to their infants for a variety of reasons, and we have to find a way to obtain a substitute for breast milk in a manner that will replace it.
Milk is the most nearly perfect food which can be obtained from nature by people so far, and not only can provide high-quality animal protein, milk fat, vitamins and the like required by the growth and development of the body and the brain of people, but also can be the best choice for supplementing calcium to the human body.
However, breast milk differs greatly from cow's milk in its composition, for example, fatty acid composition differs greatly from breast milk, and it lacks linoleic acid and linolenic acid, and also lacks ARA and DHA. In the prior art, a lot of infant milk powder is required to be close to breast milk, so people are constantly exploring and striving to make the component proportion of the infant milk powder closer to the breast milk from the aspects of components and functions.
Meanwhile, in the existing society, the rhythm of life of people is faster, and the problems of wrong proportion, pollution and the like easily occur due to the fact that cooled boiled water is used for making milk powder for infants. Therefore, people are always striving to obtain baby liquid milk to replace baby milk powder to some extent. However, for technical reasons, there are problems such as precipitation of proteins in infant liquid milk at the time of sterilization.
Disclosure of Invention
[ OBJECTS OF THE INVENTION ]
The purpose of the invention is as follows: the invention discloses liquid milk suitable for infants from birth to 6 months, which not only can meet the nutritional requirements of the infants, but also is convenient and easy to use, and can keep the stability of liquid properties.
The invention aims to take fresh cow milk (or reconstituted milk), concentrated whey protein, desalted whey powder, lactose, vegetable fat powder, compound vitamin, compound mineral substance, emulsion stabilizer and the like as raw materials according to the nutritional composition of infants and breast milk, and the whey protein is added according to the component proportion of the breast milk, so that the proportion of casein and the whey protein is close to that of the breast milk and is easy to be digested and absorbed by babies; lactose is added to supplement the carbohydrate; especially, the algae DHA is added to promote the brain and intelligence development of the infant. The formula designed by the invention ensures that the nutrient components of the liquid milk are more reasonable so as to meet the healthy growth and development of infants. Compared with fresh milk and common milk powder, the product has the advantages of scientific nutrition proportion, fragrant and strong flavor and convenient eating. The baby milk designed by the invention is suitable for 0-6 month babies to eat.
[ technical contents ]
The product of the invention is realized by the following steps:
liquid milk suitable for infants from birth to 6 months, which is characterized in that: the product comprises the following components in percentage by weight: 200Kg of milk or reconstituted milk, 1 to 10Kg of concentrated whey protein 34 (the content of whey protein is 33%), 20 to 100Kg of desalted whey powder D70 (the content of whey protein is 12%), 20 to 100Kg of vegetable fat powder, 1 to 10Kg of lactose, 500g of compound vitamin, 200 to 600g of compound mineral, 1 to 8Kg of stabilizer, 700Kg of water, and 0.1 to 1Kg of algae DHA (docosatetraenoic acid).
The above-mentioned whey protein is added in such a ratio that the weight ratio of whey protein to casein in the final product is in the range of (7:3) to (1:1), and the preferred weight ratio is 3: 2.
The above whey protein is derived from concentrated whey protein or desalted whey powder.
The above proportion is the invention point of the invention, because the liquid baby milk will be heated in the final sterilization, the protein will produce the phenomenon such as precipitation, because the baby milk powder does not contain water, the final product is not affected, but the invention is the liquid baby milk, the selection requirement to the protein source is different, the invention adds the concentrated whey protein or the desalted whey powder according to the proportion not only can meet the protein requirement of the baby in this month, the selected component is closest to the breast milk, and will not produce the precipitation in the heating, and the advantage of using the concentrated whey protein or the desalted whey powder is that the protein is prevented from being denatured in the heating sterilization, because it has better heat stability.
The reconstituted milk refers to a dairy product which is produced by reconstituting whole milk powder, skim milk powder or cream with water and is similar to a liquid milk component.
The above whey protein is derived from concentrated Whey Protein (WPC) or desalted whey powder; the preferred preparation method of the concentrated whey protein 34(WPC34) comprises the following steps: the whey is produced by membrane treatment, evaporation, concentration and spray drying, the whey protein content is more than or equal to 33 percent, and the heat stability is good.
The desalted whey powder D70 is characterized in that: the protein is produced by carrying out membrane treatment, evaporation, concentration and spray drying on whey, wherein the content of whey protein is more than or equal to 12 percent, the ash content is less than or equal to 0.1 percent, and the heat stability is good.
The above-mentioned vegetable fat powder is preferably added in such a ratio that the weight ratio of linoleic acid to alpha-linolenic acid in the final product is in the range of (5:1) to (15: 1).
The vegetable fat powder is as follows: the natural soybean oil and the corn oil clear are produced by refining, evaporating, concentrating and spray drying, the content of unsaturated fatty acid is more than or equal to 50 percent, and the thermal stability is good.
The above carbohydrate is lactose or oligosaccharide, preferably the oligosaccharide is: malto-oligosaccharide, isomaltooligosaccharide, raffinose (consisting of glucose, fructose and galactose), stachyose (consisting of trisaccharide constituting raffinose plus one galactose), soybean oligosaccharide (a-galactosides, mainly consisting of stachyose tetrasaccharide, raffinose, Vabasose and the like, which are commercially available), lactose and chicory plants.
In order to stabilize the properties of the final product of the infant liquid milk, the production processes of the concentrated whey protein 34 and the desalted whey powder D70 are respectively as follows:
preparation of concentrated whey protein 34:
pretreatment of whey
Firstly, removing bacterial starter cells in whey by adopting an automatic slag discharge and centrifugal separator;
② whey ultrafiltration
A suitable temperature for ultrafiltration is 50 deg.C (up to 55 deg.C). For products with protein content over 60-65%, heavy filtration is necessary.
(iii) drying
The trapped fluid after ultrafiltration needs to be stored under the refrigeration condition (4 ℃), and the trapped fluid can be subjected to heat treatment at 66-72 ℃ for 15s, so that the total number of bacteria can be reduced.
Said desalted whey powder is selected from: the protein is produced by carrying out membrane treatment, evaporation, concentration and spray drying on whey, wherein the content of whey protein is more than or equal to 12 percent, the ash content is less than or equal to 0.1 percent, and the heat stability is good.
The production process of the desalted whey powder D70 is as follows:
pretreatment of whey → desalination → sterilization → concentration → pre-crystallization of lactose → spray drying (roller drying) → cooling → sifting powder → packaging
The technical points are as follows:
pretreatment of whey
The casein particles in the whey are first removed and then the fat and the residue in the whey are separated and removed.
② desalting
Whey desalination is commonly carried out by an ion exchange resin method and an electrodialysis method using an ion exchange membrane.
③ Disinfection
The sterilization conditions were 85 ℃ for 15 s.
Fourthly, concentration
Concentrating whey to dry matter concentration of about 30%, and concentrating with another set of evaporator to final desired concentration
Pre-crystallization of lactose
Keeping the temperature of the mixture in a crystallization cylinder at about 20 ℃ for 3-4 h, and controlling the stirring speed at about 10r/min
Spray drying (or roller drying)
The advantages are that: the proportion and the process are the invention points of the invention, because the liquid infant milk can generate precipitation and other phenomena due to heating in the final sterilization, the final product is not affected because the infant milk powder does not contain water, but the liquid infant milk of the invention has different selection requirements on protein sources, the concentrated whey protein or the desalted whey powder added according to the proportion in the invention can not only meet the protein requirements of infants in the month, the selected components are most close to the breast milk, but also can not generate precipitation in the heating process, and the concentrated whey protein or the desalted whey powder has the advantages of avoiding the protein from being denatured in the heating sterilization process because the concentrated whey protein or the desalted whey powder has better heat stability.
The above vegetable fat powder is selected from: the fat powder is produced by refining, evaporating, concentrating and spray drying natural soybean oil and corn oil clear, the content of unsaturated fatty acid is more than or equal to 50 percent, and the heat stability is good. The production process of the vegetable fat powder comprises the following steps:
(emulsification before the previous process and preparation similar to milk powder) oil phase dissolution adjustment (natural soybean oil, corn oil, etc.) + water phase adjustment (seipan, sucrose ester, single or double glycerol ester, flavor substance, carrier) → primary emulsification → fine emulsification → homogenization → sterilization → double effect evaporator concentration or perfuming → spray drying → fluidized bed cooling → sieving powder → packaging → packing → inspection → finished product
The advantages are that: the ratio of the vegetable fat powder is such that the weight ratio of linoleic acid to alpha-linolenic acid in the final product is in the range of (5:1) - (15: 1). Is closer to breast milk and is beneficial to the nutrition requirement of the infant. Meanwhile, linoleic acid and alpha-linolenic acid are precursors of docosahexaenoic acid and arachidonic acid and can promote the intelligence development of infants.
The emulsion stabilizer is selected from: one or more of phospholipid, carrageenan, guar gum, locust bean gum, mono/di/tri fatty acid glyceride, monoglyceride, sucrose ester, etc.; the addition amount is 0.01-0.6% by weight; the preferred range is 0.1% -0.4%; wherein, the preferred combination of carrageenan (the addition amount is 0.01-0.05% by weight), locust bean gum (the addition amount is 0.02-0.08% by weight), and mono/di/triglyceride (the addition amount is 0.02-0.08% by weight); or preferably guar gum (added in an amount of 0.05-0.1 wt%), mono/di/triglyceride (added in an amount of 0.02-0.05 wt%), and mono-dry ester (added in an amount of 0.02-0.05 wt%); or preferably phospholipid (added in an amount of 0.05-0.1 wt%), mono/di/triglyceride (added in an amount of 0.02-0.05 wt%), and sucrose ester (added in an amount of 0.05-0.1 wt%).
The weight ratio of the compound vitamin is as follows:
vitamin A1375.3-5394.6 IU, vitamin D3252-884IU, 3-35.3U of vitamin E, 62.5-442mg of vitamin C, 25-191.8 mu g of vitamin K and vitamin B1350-2350-3510.5 μ g, vitamin B6212.5-1327.5 μ g, vitamin B120.625-10.6 mu g, 1.75-11.06mg nicotinic acid, 14100 mu g pantothenic acid 2375, 62.5-354 mu g folic acid and 10-70.8 mu g biotin.
The composite mineral substance is one or a combination of a plurality of the following components in percentage by weight: 350-1302.5mg of calcium, 150 mg of phosphorus, 708mg of magnesium, 30-106.2mg of magnesium, 350-1268.5mg of potassium, 1.8-38.4mg of iron and 3-10.6mg of zinc
mg, sodium 125-413mg, iodine 4-40 μ g, copper 210-855.5 μ g, manganese 6.25-734.5 μ g.
Preferably, the added minerals are iron, zinc, calcium, magnesium, iodine, manganese and copper sources:
the iron is provided by one or more iron preparations such as ferrous gluconate, ferrous sulfate, ferrous lactate, ferric citrate, ferric pyrophosphate, etc.;
the zinc is provided by one or a combination of zinc preparations such as zinc sulfate, zinc gluconate, zinc lactate, zinc chloride and the like;
the calcium is provided by one or more calcium preparations such as milk calcium, calcium citrate, calcium phosphate, calcium chloride, calcium carbonate, calcium lactate, etc.;
the magnesium is provided by one or more magnesium preparations such as magnesium sulfate, magnesium chloride, magnesium citrate, etc.;
iodine is provided by potassium iodide;
manganese is provided by manganese sulfate;
the copper is provided by copper sulfate.
Because the metal elements can react with enzyme substances in the milk to cause chemical reactions such as precipitation, discoloration and the like, the invention selects mineral substances to add aiming at the problems, not only can supplement nutrient elements for infants, but also can not influence the properties of products, and is creative in the invention. After long-term research, the inventors found that the above-mentioned problems can be avoided by selecting the above-mentioned compounds when the above-mentioned metal elements are added, and that the above-mentioned compounds do not cause any chemical reactions such as precipitation and discoloration even when combined. Therefore, in the selection of the trace elements, the invention determines the type and amount of the added minerals according to the nutrient content of the designed product. The advantages are that: the selected mineral elements are colorless, odorless, do not significantly affect the properties of milk, are soluble in water, have stable chemical properties and high absorption rate, do not have obvious promotion effect on adverse enzyme reactions in milk, and have proper specific gravity.
The sugar is selected from: the lactose is produced by membrane separation, evaporation, concentration and spray drying of natural whey, the lactose content is more than or equal to 99 percent, and the lactose has good thermal stability and solubility.
The algae DHA is selected from: from natural sources, whole plant sources are the most readily digestible triglyceride form by humans (as is DHA form in breast milk); without any substances present in too high a quantity, such as phospholipids and cholesterol; without any marine contaminants and toxic substances that may be present in fish oil; has excellent bioavailability for infants. Wherein the DHA is embedded with a stabilizing material before use, and when the DHA is added, AA is also added, preferably the weight of the AA is 1.9 times that of the DHA, wherein the more preferable weight ratio of the AA to the DHA is 1.8-2.3: 1, and the preferable coating material for embedding the DHA is as follows: modified starch and maltodextrin.
The preparation method of the infant liquid milk comprises the following steps:
(1) checking and accepting raw milk; (2) pretreating raw milk; (3) preparing materials; (4) preheating and homogenizing; (5) sterilizing; (6) cooling; (7) sterile addition; (8) sterile filling and obtaining finished products; wherein,
(1) checking and accepting the raw milk:
the method mainly aims at detecting acidity, fat, whole milk solid, specific gravity, adulteration (starch, alkali, salt, nitrite and the like), antibiotics, taste and smell and the like, and qualified high-quality milk is used as raw milk. Substances harmful to human bodies, such as nitrate, pesticide residues, antibiotics and the like, in the milk are strictly controlled.
(2) Pretreating raw milk:
coarse filtering cow milk with gauze or duplex filter to remove large foreign matters and impurities; after centrifugal milk cleaning, fine dirt, desquamated breast epithelial tissues, white blood cells and the like are removed, high milk cleaning is achieved, and the product quality is improved. In order to obtain a finished product with stable composition components, standardization must be performed to achieve a balance between milk fat and non-fat milk solids, etc. The storage temperature is about 4 ℃.
(3) Preparing materials:
pumping the pretreated milk into a mixing tank. If reconstituted milk is used, whole milk powder, skim milk powder or cream (or butter) is reconstituted (45 ℃) and pumped into a mixing tank.
Adding water at 45 deg.C, mixing with whey protein concentrate, desalted whey powder, and lactose, recovering, and adding into a mixing tank.
Mixing the plant fat powder with the emulsion stabilizer, mixing with water at a temperature of above 65 ℃, and adding into a mixing tank.
Adding water at 25 deg.C, mixing with vitamins, and adding into mixing tank.
Algae DHA is accurately weighed and is directly added into the mixing tank.
Stirring, uniformly mixing and fixing the volume:
adding the materials into a mixing tank, stirring for 5-20min, supplementing water, and fixing volume.
(4) Preheating and homogenizing:
preheating: the preheating temperature is 65-90 ℃.
Homogenizing: homogenizing pressure: the total pressure is 18-25Mpa, the first-stage pressure is 10-20Mpa, and the second-stage pressure is 8-10 Mpa.
(5) UHT sterilization:
the sterilization temperature is 137-142 ℃, and the sterilization time is 2-4 seconds. UHT sterilization can adopt various sterilization modes such as tubular steam sterilization and plate steam sterilization;
(6) and (3) cooling:
cooling the milk instantly sterilized at ultra-high temperature to about 15-30 deg.C. The sterilized milk enters an aseptic tank.
(7) Sterile addition
For the heat-sensitive nutritional components, an online adding process is selected, the heat-sensitive components are stored in a sterile bag or a sterile tank in a liquid sterile state, a sterile adding system is connected, and the heat-sensitive components are added into the sterile tank or quantitatively added into a pipeline.
(8) And (4) sterile filling, and obtaining a finished product:
and (5) sterile filling and packaging, and sending the qualified product into a finished product warehouse.
In addition, in the selection of the trace elements, the invention determines the type and the amount of the added minerals according to the nutrient content of the designed product. The advantages are that: the selected mineral elements are colorless, odorless, do not significantly affect the properties of milk, are soluble in water, have stable chemical properties and high absorption rate, do not have obvious promotion effect on adverse enzyme reactions in milk, and have proper specific gravity.
While excessive amounts of copper and iron promote the oxidation of milk fat and vegetable oils, which causes the liquid milk to have a bad flavor, the selection of copper and iron compounds in the present invention is inventive, because only the selected compounds of the present invention can provide the final product in a stable liquid state without oxidation, which is the result of many experiments conducted by the present inventors.
The product of the invention is prepared by adopting a conventional mixing and adding mode for other raw materials, the preferred sterile online adding technology of the vitamin complex is as follows:
(1) checking and accepting the raw milk:
the method mainly aims at detecting acidity, fat, whole milk solid, specific gravity, adulteration (starch, alkali, salt, nitrite and the like), antibiotics, taste and smell and the like, and qualified high-quality milk is used as raw milk. Substances harmful to human bodies, such as nitrate, pesticide residues, antibiotics and the like, in the milk are strictly controlled.
(2) Pretreating raw milk:
coarse filtering cow milk with gauze or duplex filter to remove large foreign matters and impurities; after centrifugal milk cleaning, fine dirt, desquamated breast epithelial tissues, white blood cells and the like are removed, high milk cleaning is achieved, and the product quality is improved. In order to obtain a finished product with stable composition components, standardization must be performed to achieve a balance between milk fat and non-fat milk solids, etc. The storage temperature is about 4 ℃.
(3) Preparing materials:
pumping the pretreated milk into a mixing tank. If reconstituted milk is used, whole milk powder, skim milk powder or cream (or butter) is reconstituted (45 ℃) and pumped into a mixing tank.
Adding water at 45 deg.C, mixing with whey protein concentrate, desalted whey powder, and lactose, recovering, and adding into a mixing tank.
Mixing the plant fat powder with the emulsion stabilizer, mixing with water at a temperature of above 65 ℃, and adding into a mixing tank.
Adding water at 25 deg.C, mixing with vitamins, and adding into mixing tank.
Stirring, uniformly mixing and fixing the volume:
adding the materials into a mixing tank, stirring for 5-20min, supplementing water, and fixing volume.
(4) Preheating and homogenizing:
preheating: the preheating temperature is 65-90 ℃.
Homogenizing: homogenizing pressure: the total pressure is 18-25Mpa, the first-stage pressure is 10-20Mpa, and the second-stage pressure is 8-10 Mpa.
(5) UHT sterilization:
the sterilization temperature is 137-142 ℃, and the sterilization time is 2-4 seconds. UHT sterilization can adopt various sterilization modes such as tubular steam sterilization, plate steam sterilization and the like.
(6) And (3) cooling:
cooling the milk instantly sterilized at ultra-high temperature to about 15-30 deg.C. The sterilized milk enters an aseptic tank.
(7) Sterile on-line addition:
for heat-sensitive nutritional components such as vitamin C, an on-line addition process (post-sterilization addition process) is selected. Namely, the compound vitamin is stored in a sterile bag (or a tank, etc.) in a liquid sterile state, and is connected with a sterile adding system to add the heat-sensitive component into the sterile tank or quantitatively add the heat-sensitive component into a pipeline.
(8) And (4) sterile filling, and obtaining a finished product:
and (5) sterile filling and packaging, and sending the qualified product into a finished product warehouse.
[ Effect of the invention ]
1. The algae DHA comes from nature, and the whole plant resource is the triglyceride form which is most easily digested by human body (the same as the DHA form in the breast milk); has excellent bioavailability for infants, and is more beneficial to the development of the intelligence of the infants.
2. The optimized sterile adding method provides important guarantee for the stability and safety of the heat-sensitive components contained in the product.
3. According to the proportion of the components of the breast milk, the concentrated whey protein and the desalted whey powder are added, so that the amounts of the casein and the whey protein are consistent with the amount of the breast milk, and the casein and the whey protein are easy to be digested and absorbed by babies. The use of concentrated whey protein and desalted whey powder, in the form of liquid milk, has the advantage of avoiding denaturation of the protein during heat sterilization, and because of its better heat stability, the weight ratio of whey protein to casein in breast milk is 3:2, so the selected components of the present invention most closely approach that of breast milk.
4. According to the proportion of the components of breast milk, the plant fat powder is added, so that the weight ratio of the linoleic acid to the alpha-linolenic acid in the final product is (5:1) - (15: 1). Is closer to breast milk and is beneficial to the nutrition requirement of the infant. Meanwhile, linoleic acid and alpha-linolenic acid are precursors of docosahexaenoic acid and arachidonic acid and can promote the intelligence development of infants.
5. According to the actual formula of the invention, the formula of the stabilizer is selected, so that the final product has stable properties.
6. Compared to infant milk powder, liquid infant milk has many advantages, such as: no need of mixing, constant concentration, convenient feeding, safety, sanitation, etc. The development of the infant formula towards the liquid state becomes great tendency, the development prospect is wide, and the economic benefit and the social benefit are higher.
Detailed Description
The embodiments of the present invention are intended to illustrate rather than limit the scope of the present invention, and it should be clearly understood and appreciated by those skilled in the art that the range of proportions disclosed in the specification is intended to be a complete and flawless practice of the present invention, and any slight differences in nutritional ingredients due to differences in milk sources should not be considered as a reason that the examples of the present invention are not in accordance with the specification, and therefore the present invention is intended to protect the spirit of the addition of nutrients, and is not intended to be particularly restricted to a specific value.
Due to the differences of the milk products, the added components cannot be clearly and strictly limited in the examples to be exactly the same as the ranges defined in the specification, and the following examples are also the same. One of ordinary skill in the art will understand and be able to practice the present invention in light of the disclosed data and methods.
Example 1
Taking the production of one ton of the product of the invention as an example, the ingredients are as follows:
200Kg of milk, 10Kg of concentrated whey protein 34 (the content of whey protein is 33%), 100Kg of desalted whey powder D70 (the content of whey protein is 12%), 100Kg of vegetable fat powder, 10Kg of lactose, 500g of compound vitamin, 600g of compound mineral, 8Kg of stabilizer, 0.1Kg of algae DHA, and the balance of water. The algae DHA is selected from: from natural sources, whole plant sources are the most readily digestible triglyceride form by humans (as is DHA form in breast milk); without any substances present in too high a quantity, such as phospholipids and cholesterol; without any marine contaminants and toxic substances that may be present in fish oil; has excellent bioavailability for infants. Wherein, the DHA is embedded with a stability material before use, and when the DHA is added, AA is also added, the weight of the DHA is 2.3 times of that of the DHA, and the preferable coating material for embedding the DHA is as follows: modified starch.
Wherein the selection of the compound vitamin and the compound mineral substance is in the following range, and the compound vitamin with the total weight of 500g and the compound mineral substance with the total weight of 600g are obtained:
vitamin A1375.3-5394.6 IU, vitamin D3252-884IU, 3-35.3U of vitamin E, 62.5-442mg of vitamin C, 25-191.8 mu g of vitamin K and vitamin B1350-2350-3510.5 μ g, vitamin B6212.5-1327.5 μ g, vitamin B120.625-10.6 mu g, 1.75-11.06mg nicotinic acid, 14100 mu g pantothenic acid 2375, 62.5-354 mu g folic acid and 10-70.8 mu g biotin.
The composite mineral substance is one or a combination of a plurality of the following components in percentage by weight: 350-1302.5mg of calcium, 708mg of phosphorus 150-19 mg, 30-106.2mg of magnesium, 350-1268.5mg of potassium, 1.8-38.4mg of iron, 3-10.6mg of zinc, 413mg of sodium 125-40 μ g of iodine, 210-855.5 μ g of copper and 6.25-734.5 μ g of manganese.
The emulsion stabilizer is selected as follows: carrageenan (added in 0.01 wt%), locust bean gum (added in 0.08 wt%), and mono/di/tri fatty acid glyceride (added in 0.08 wt%).
The preparation method comprises the following steps:
(1) checking and accepting the raw milk:
the method mainly aims at detecting acidity, fat, whole milk solid, specific gravity, adulteration (starch, alkali, salt, nitrite and the like), antibiotics, taste and smell and the like, and qualified high-quality milk is used as raw milk. Substances harmful to human bodies, such as nitrate, pesticide residues, antibiotics and the like, in the milk are strictly controlled.
(2) Pretreating raw milk:
coarse filtering cow milk with gauze or duplex filter to remove large foreign matters and impurities; after centrifugal milk cleaning, fine dirt, desquamated breast epithelial tissues, white blood cells and the like are removed, high milk cleaning is achieved, and the product quality is improved. In order to obtain a finished product with stable composition components, standardization must be performed to achieve a balance between milk fat and non-fat milk solids, etc. The storage temperature is about 4 ℃.
(3) Preparing materials:
pumping the pretreated milk into a mixing tank. If reconstituted milk is used, whole milk powder, skim milk powder or cream (or butter) is reconstituted (45 ℃) and pumped into a mixing tank.
Adding water at 45 deg.C, mixing with whey protein concentrate, desalted whey powder, and lactose, recovering, and adding into a mixing tank.
Mixing the plant fat powder with the emulsion stabilizer, mixing with water at a temperature of above 65 ℃, and adding into a mixing tank.
Adding water at 25 deg.C, mixing with vitamins, and adding into mixing tank.
Stirring, uniformly mixing and fixing the volume:
and adding the materials into a mixing tank, stirring for 20 minutes, supplementing water and fixing the volume.
(4) Preheating and homogenizing:
preheating: the preheating temperature was 65 ℃.
Homogenizing: homogenizing pressure: the total pressure is 18MPa, the primary pressure is 10MPa, and the secondary pressure is 8 MPa.
(5) UHT steam spray direct sterilization:
the sterilization temperature is 145 ℃, and the sterilization time is 4 seconds.
(6) And (3) cooling:
cooling the milk sterilized instantaneously at ultra-high temperature to about 15 ℃. The sterilized milk enters an aseptic tank.
(7) And (4) sterile filling, and obtaining a finished product:
and (5) sterile filling and packaging, and sending the qualified product into a finished product warehouse.
Example 2
Taking the production of one ton of the product of the invention as an example, the ingredients are as follows:
220Kg of milk, 8Kg of concentrated whey protein 34 (the content of whey protein is 33%), 70Kg of desalted whey powder D70 (the content of whey protein is 12%), 70Kg of vegetable fat powder, 4Kg of lactose, 230g of vitamin complex, 420g of compound mineral, 3.8Kg of stabilizer, 0.4Kg of algae DHA, and the balance of water. The algae DHA is selected from: from natural sources, whole plant sources are the most readily digestible triglyceride form by humans (as is DHA form in breast milk); without any substances present in too high a quantity, such as phospholipids and cholesterol; without any marine contaminants and toxic substances that may be present in fish oil; has excellent bioavailability for infants. Wherein, the DHA is embedded with a stability material before use, and when the DHA is added, AA is also added, the weight of the DHA is 1.9 times of that of the DHA, and the preferable coating material for embedding the DHA is as follows: modified starch.
Wherein the selection of the compound vitamin and the compound mineral substance is in the following proportion range, and the compound vitamin with the total weight of 230g and the compound mineral substance with the total weight of 420g are obtained:
vitamin A1375.3-5394.6 IU, vitamin D3252-884IU, 3-35.3U of vitamin E, 62.5-442mg of vitamin C, 25-191.8 mu g of vitamin K and vitamin B1350-2350-3510.5 μ g, vitamin B6212.5-1327.5 μ g, vitamin B120.625-10.6 mu g, 1.75-11.06mg nicotinic acid, 14100 mu g pantothenic acid 2375, 62.5-354 mu g folic acid and 10-70.8 mu g biotin.
The composite mineral substance is one or a combination of a plurality of the following components in percentage by weight: 350-1302.5mg of calcium, 708mg of phosphorus 150-19 mg, 30-106.2mg of magnesium, 350-1268.5mg of potassium, 1.8-38.4mg of iron, 3-10.6mg of zinc, 413mg of sodium 125-40 μ g of iodine, 210-855.5 μ g of copper and 6.25-734.5 μ g of manganese.
The emulsion stabilizer is selected as follows: carrageenan (added in 0.05 wt%), locust bean gum (added in 0.08 wt%), and mono/di/tri fatty acid glyceride (added in 0.08 wt%).
The preparation method comprises the following steps:
(1) checking and accepting the raw milk:
the method mainly aims at detecting acidity, fat, whole milk solid, specific gravity, adulteration (starch, alkali, salt, nitrite and the like), antibiotics, taste and smell and the like, and qualified high-quality milk is used as raw milk. Substances harmful to human bodies, such as nitrate, pesticide residues, antibiotics and the like, in the milk are strictly controlled.
(2) Pretreating raw milk:
coarse filtering cow milk with gauze or duplex filter to remove large foreign matters and impurities; after centrifugal milk cleaning, fine dirt, desquamated breast epithelial tissues, white blood cells and the like are removed, high milk cleaning is achieved, and the product quality is improved. In order to obtain a finished product with stable composition components, standardization must be performed to achieve a balance between milk fat and non-fat milk solids, etc. The storage temperature is about 4 ℃.
(3) Preparing materials:
pumping the pretreated milk into a mixing tank. If reconstituted milk is used, whole milk powder, skim milk powder or cream (or butter) is reconstituted (45 ℃) and pumped into a mixing tank.
Adding water at 45 deg.C, mixing with whey protein concentrate, desalted whey powder, and lactose, recovering, and adding into a mixing tank.
Mixing the plant fat powder with the emulsion stabilizer, mixing with water at a temperature of above 65 ℃, and adding into a mixing tank.
Adding water at 25 deg.C, mixing with vitamins, and adding into mixing tank.
Stirring, uniformly mixing and fixing the volume:
adding the materials into a mixing tank, stirring for 5min, supplementing water, and fixing volume.
(4) Preheating and homogenizing:
preheating: the preheating temperature was 90 ℃.
Homogenizing: homogenizing pressure: the total pressure is 25MPa, the primary pressure is 20MPa, and the secondary pressure is 10 MPa.
(5) UHT steam spray direct sterilization:
the sterilization temperature is 138 ℃, and the sterilization time is 6 seconds.
(6) And (3) cooling:
cooling the milk sterilized instantaneously at ultra-high temperature to about 30 ℃. The sterilized milk enters an aseptic tank.
(7) And (4) sterile filling, and obtaining a finished product:
and (5) sterile filling and packaging, and sending the qualified product into a finished product warehouse.
Example 3
Taking the production of one ton of the product of the invention as an example, the ingredients are as follows:
200Kg of milk, 1Kg of concentrated whey protein 34 (the content of whey protein is 33%), 20Kg of desalted whey powder D70 (the content of whey protein is 12%), 20Kg of vegetable fat powder, 1Kg of lactose, 100g of compound vitamin, 200g of compound mineral, 1Kg of stabilizer, 0.5Kg of algae DHA, and the balance of water. Wherein the selection of the compound vitamin and the compound mineral substance is in the following range, and the compound vitamin with the total weight of 100g and the compound mineral substance with the total weight of 200g are obtained:
vitamin A1375.3-5394.6 IU, vitamin D3252-884IU, 3-35.3U of vitamin E, 62.5-442mg of vitamin C, 25-191.8 mu g of vitamin K and vitamin B1350-2350-3510.5 μ g, vitaminB6212.5-1327.5 μ g, vitamin B120.625-10.6 mu g, 1.75-11.06mg nicotinic acid, 14100 mu g pantothenic acid 2375, 62.5-354 mu g folic acid and 10-70.8 mu g biotin.
The composite mineral substance is one or a combination of a plurality of the following components in percentage by weight: 350-1302.5mg of calcium, 708mg of phosphorus 150-19 mg, 30-106.2mg of magnesium, 350-1268.5mg of potassium, 1.8-38.4mg of iron, 3-10.6mg of zinc, 413mg of sodium 125-40 μ g of iodine, 210-855.5 μ g of copper and 6.25-734.5 μ g of manganese.
The emulsion stabilizer is selected as follows: carrageenan (added in 0.01 wt%), locust bean gum (added in 0.02 wt%), and mono/di/tri fatty acid glyceride (added in 0.02 wt%).
(1) Checking and accepting the raw milk:
the method mainly aims at detecting acidity, fat, whole milk solid, specific gravity, adulteration (starch, alkali, salt, nitrite and the like), antibiotics, taste and smell and the like, and qualified high-quality milk is used as raw milk. Substances harmful to human bodies, such as nitrate, pesticide residues, antibiotics and the like, in the milk are strictly controlled.
(2) Pretreating raw milk:
coarse filtering cow milk with gauze or duplex filter to remove large foreign matters and impurities; after centrifugal milk cleaning, fine dirt, desquamated breast epithelial tissues, white blood cells and the like are removed, high milk cleaning is achieved, and the product quality is improved. In order to obtain a finished product with stable composition components, standardization must be performed to achieve a balance between milk fat and non-fat milk solids, etc. The storage temperature is about 4 ℃.
(3) Preparing materials:
pumping the pretreated milk into a mixing tank. If reconstituted milk is used, whole milk powder, skim milk powder or cream (or butter) is reconstituted (45 ℃) and pumped into a mixing tank.
Adding water at 45 deg.C, mixing with whey protein concentrate, desalted whey powder, and lactose, recovering, and adding into a mixing tank.
Mixing the plant fat powder with the emulsion stabilizer, mixing with water at a temperature of above 65 ℃, and adding into a mixing tank.
Adding water at 25 deg.C, mixing with vitamins, and adding into mixing tank.
Stirring, uniformly mixing and fixing the volume:
adding the materials into a mixing tank, stirring for 20min, supplementing water, and fixing volume.
(4) Preheating and homogenizing:
preheating: the preheating temperature is 65-90 ℃.
Homogenizing: homogenizing pressure: the total pressure is 25MPa, the primary pressure is 20MPa, and the secondary pressure is 10 MPa.
(5) UHT sterilization:
the sterilization temperature is 142 ℃ and the sterilization time is 2 seconds. UHT sterilization can adopt various sterilization modes such as tubular steam sterilization, plate steam sterilization and the like.
(6) And (3) cooling:
cooling the milk sterilized instantaneously at ultra-high temperature to about 15 ℃. The sterilized milk enters an aseptic tank.
(7) Sterile on-line addition:
for the heat-sensitive nutritional component vitamins, an online addition process (post-sterilization addition process) is selected. Namely, the compound vitamin is stored in a sterile bag (or a tank, etc.) in a liquid sterile state, and is connected with a sterile adding system to add the heat-sensitive component into the sterile tank or quantitatively add the heat-sensitive component into a pipeline.
(8) And (4) sterile filling, and obtaining a finished product:
and (5) sterile filling and packaging, and sending the qualified product into a finished product warehouse.
Example 4
Taking the production of one ton of the product of the invention as an example, the ingredients are as follows:
500Kg of milk, 10Kg of concentrated whey protein 34 (whey protein content is 33%), 100Kg of desalted whey powder D70 (whey protein content is 12%), 100Kg of vegetable fat powder, 10Kg of lactose, 500g of vitamin complex, 600g of compound mineral, 8Kg of stabilizer, algae DHA1Kg, and the balance of water. Wherein the selection of the compound vitamin and the compound mineral substance is in the following range, and the compound vitamin with the total weight of 500g and the compound mineral substance with the total weight of 600g are obtained:
vitamin A1375.3-5394.6 IU, vitamin D3252-884IU, 3-35.3U of vitamin E, 62.5-442mg of vitamin C, 25-191.8 mu g of vitamin K and vitamin B1350-2350-3510.5 μ g, vitamin B6212.5-1327.5 μ g, vitamin B120.625-10.6 mu g, 1.75-11.06mg nicotinic acid, 14100 mu g pantothenic acid 2375, 62.5-354 mu g folic acid and 10-70.8 mu g biotin.
The composite mineral substance is one or a combination of a plurality of the following components in percentage by weight: 350-1302.5mg of calcium, 708mg of phosphorus 150-19 mg, 30-106.2mg of magnesium, 350-1268.5mg of potassium, 1.8-38.4mg of iron, 3-10.6mg of zinc, 413mg of sodium 125-40 μ g of iodine, 210-855.5 μ g of copper and 6.25-734.5 μ g of manganese.
The emulsion stabilizer is selected from: guar gum (added in an amount of 0.1% by weight), mono/di/triglyceride (added in an amount of 0.05% by weight), and monoglyceride (added in an amount of 0.05% by weight).
The preparation method is the same as example 1.
Example 5
Taking the production of one ton of the product of the invention as an example, the ingredients are as follows:
250Kg of milk, 5Kg of concentrated whey protein 34 (the content of whey protein is 33%), 53Kg of desalted whey powder D70 (the content of whey protein is 12%), 40Kg of vegetable fat powder, 1Kg of lactose, 130g of compound vitamin, 330g of compound mineral, 3.3Kg of stabilizer, 0.8Kg of algae DHA0, and the balance of water. Wherein the selection of the compound vitamin and the compound mineral substance is in the following range, and the compound vitamin with the total weight of 250g and the compound mineral substance with the total weight of 450g are obtained:
vitamin A1375.3-5394.6 IU, vitamin D3252-884IU, 3-35.3U of vitamin E, 62.5-442mg of vitamin C, 25-191.8 mu g of vitamin K and vitamin B1350-2350-3510.5 μ g, vitamin B6212.5-1327.5 μ g, vitamin B120.625-10.6 mu g, 1.75-11.06mg nicotinic acid, 14100 mu g pantothenic acid 2375, 62.5-354 mu g folic acid and 10-70.8 mu g biotin.
The composite mineral substance is one or a combination of a plurality of the following components in percentage by weight: 350-1302.5mg of calcium, 708mg of phosphorus 150-19 mg, 30-106.2mg of magnesium, 350-1268.5mg of potassium, 1.8-38.4mg of iron, 3-10.6mg of zinc, 413mg of sodium 125-40 μ g of iodine, 210-855.5 μ g of copper and 6.25-734.5 μ g of manganese.
The emulsion stabilizer is selected from: guar gum (added in an amount of 0.05% by weight), mono/di/triglyceride (added in an amount of 0.02% by weight), and a mono dry ester (added in an amount of 0.02% by weight).
The preparation method is the same as example 2.
Example 6
Taking the production of one ton of the product of the invention as an example, the ingredients are as follows:
240Kg of milk, 6Kg of concentrated whey protein 34 (the content of whey protein is 33%), 55Kg of desalted whey powder D70 (the content of whey protein is 12%), 50Kg of vegetable fat powder, 2Kg of lactose, 200g of vitamin complex, 350g of compound mineral, 3.4Kg of stabilizer and the balance of water. Wherein the selection of the compound vitamin and the compound mineral substance is in the following range, and the compound vitamin with the total weight of 200g and the compound mineral substance with the total weight of 350g are obtained:
vitamin A1375.3-5394.6 IU, vitamin D3252-884IU, 3-35.3U of vitamin E, 62.5-442mg of vitamin C, 25-191.8 mu g of vitamin K and vitamin B1350-2 350-3510.5μg、Vitamin B6212.5-1327.5 μ g, vitamin B120.625-10.6 mu g, 1.75-11.06mg nicotinic acid, 14100 mu g pantothenic acid 2375, 62.5-354 mu g folic acid and 10-70.8 mu g biotin.
The composite mineral substance is one or a combination of a plurality of the following components in percentage by weight: 350-1302.5mg of calcium, 708mg of phosphorus 150-19 mg, 30-106.2mg of magnesium, 350-1268.5mg of potassium, 1.8-38.4mg of iron, 3-10.6mg of zinc, 413mg of sodium 125-40 μ g of iodine, 210-855.5 μ g of copper and 6.25-734.5 μ g of manganese.
The emulsion stabilizer is selected from: phospholipid (added in an amount of 0.1% by weight), mono/di/tri fatty acid glyceride (added in an amount of 0.05% by weight), and sucrose ester (added in an amount of 0.1% by weight).
The preparation method is the same as example 3.
Example 7
Taking the production of one ton of the product of the invention as an example, the ingredients are as follows:
230Kg of milk, 7Kg of concentrated whey protein 34 (whey protein content 33%), 60Kg of desalted whey powder D70 (whey protein content 12%), 60Kg of vegetable fat powder, 3Kg of lactose, 220g of vitamin complex, 400g of compound mineral, 3.6Kg of stabilizer, 1.0Kg of algae DHA1, and the balance of water. The algae DHA is selected from: from natural sources, whole plant sources are the most readily digestible triglyceride form by humans (as is DHA form in breast milk); without any substances present in too high a quantity, such as phospholipids and cholesterol; without any marine contaminants and toxic substances that may be present in fish oil; has excellent bioavailability for infants. Wherein, the DHA is embedded with a stability material before use, and when the DHA is added, AA is also added, the weight of the DHA is 1.05 times of that of the DHA, and the preferable coating material for embedding the DHA is as follows: maltodextrin.
Wherein the selection of the compound vitamin and the compound mineral substance is in the following range, the compound vitamin with the total weight of 220g and the compound mineral substance with the total weight of 400g are obtained:
vitamin A1375.3-5394.6IU, vitamin D3252-884IU, 3-35.3U of vitamin E, 62.5-442mg of vitamin C, 25-191.8 mu g of vitamin K and vitamin B1350-2350-3510.5 μ g, vitamin B6212.5-1327.5 μ g, vitamin B120.625-10.6 mu g, 1.75-11.06mg nicotinic acid, 14100 mu g pantothenic acid 2375, 62.5-354 mu g folic acid and 10-70.8 mu g biotin.
The composite mineral substance is one or a combination of a plurality of the following components in percentage by weight: 350-1302.5mg of calcium, 708mg of phosphorus 150-19 mg, 30-106.2mg of magnesium, 350-1268.5mg of potassium, 1.8-38.4mg of iron, 3-10.6mg of zinc, 413mg of sodium 125-40 μ g of iodine, 210-855.5 μ g of copper and 6.25-734.5 μ g of manganese.
The emulsion stabilizer is selected from: phospholipid (added in an amount of 0.05% by weight), mono/di/tri fatty acid glyceride (added in an amount of 0.02% by weight), and sucrose ester (added in an amount of 0.05% by weight).
The preparation method is the same as example 3.
Although the conception and the embodiments of the present invention have been described in detail, those skilled in the art will recognize that various changes and modifications may be made therein without departing from the scope of the appended claims.
The product of the invention has the following effects:
animal tests such as acute toxicity test, genetic toxicity test, 30-day feeding test, traditional teratogenesis test and the like are carried out on the product, and the product is safe and nontoxic; and has the function of promoting the growth of mice.
300 infants born in 2006-2007 and 9-month were selected for the test, 150 infants were male and 150 infants were female. These infants are the first fetus of term, and have a weight of 2.9-3.2kg and a body length of 49-51cm at birth. No disease in 0-30 days. Infants with the same age in the month were fed with the same group of infants with no statistical difference in length, weight, and head circumference. Parents are the support or volunteers of the program. There was no statistical difference in parental cultural degree and family economic status between the two groups of infants. The screened infants do not belong to the population with lactose intolerance and milk protein inadaptation.
According to experimental design, the infant formula milk powder feeding group is divided into a male infant group and a female infant group, and each group is divided into a breast feeding group, an infant formula liquid milk group and an infant formula powder feeding group.
Feeding breast milk for 3 months, starting grouping test, and measuring the indexes of weight, body length, upper arm circumference and the like which reflect the growth and development of the infant. The recommended liquid feeding amounts are shown in table 1. The feeding amount of the formula powder is converted into the volume number of the instant state.
Table 1 suggested feeding amounts
| Mean body weight | Amount of feed | ||
| Age of the month | kg | ml | Number of times of feeding for 24h |
| 2 months old | 4.6 | 170 | 5 |
| 4 months old | 6.6 | 230 | 5 |
| 6 months old | 7.6 | 250 | 4 |
The results of different feeding modes and infant physique development are shown in table 2.
TABLE 2 feeding method and results x + -s of baby physique development
As can be seen from table 2, the differences between the infant formula group, the infant formula group and the breastfeeding group become smaller from 3 months to 6 months. That is, as the age of the infant increases, the differences in physical development of the infant from feeding to feeding are reduced. In addition, it can be seen that the infant formula group had better results of developing the physical constitution of the infants than the infant formula group. The infant formula milk overcomes the difference of water adding proportion when the formula powder is artificially fed, and ensures the reasonable content of the nutrient components; the disadvantages of non-uniformity and coarse particles in brewing are also avoided. Research shows that the infant formula milk has balanced nutrition, fine and smooth taste and easy absorption, and can meet the requirements of normal growth and development of infants.
Claims (13)
1. The liquid milk suitable for the babies of birth to 6 months old is characterized in that: the product comprises the following components in percentage by weight: 200Kg of milk, 1 to 10Kg of whey protein 34 (the content of whey protein is 33%), 20 to 100Kg of desalted whey powder D70 (the content of whey protein is 12%), 20 to 100Kg of vegetable fat powder, 1 to 10Kg of carbohydrate, 500g of vitamin complex 100-.
2. The liquid infant milk according to claim 1, wherein: the weight ratio of the added whey protein is such that the weight ratio of whey protein to casein in the final product is in the range of (7:3) - (1: 1).
3. The liquid infant milk according to claim 2, wherein: the whey protein is added in a proportion that the weight ratio of the whey protein to the casein in the final product is 3: 2.
4. The liquid infant milk according to claim 1, 2 or 3, wherein: the whey protein is derived from concentrated Whey Protein (WPC) or desalted whey powder; the preferred preparation method of the concentrated whey protein 34(WPC34) comprises the following steps: the whey is produced by membrane treatment, evaporation, concentration and spray drying, the whey protein content is more than or equal to 33 percent, and the heat stability is good.
5. The liquid infant milk according to claim 1, wherein: the desalted whey powder D70 is characterized in that: the protein is produced by carrying out membrane treatment, evaporation, concentration and spray drying on whey, wherein the content of whey protein is more than or equal to 12 percent, the ash content is less than or equal to 0.1 percent, and the heat stability is good.
6. The liquid infant milk according to claim 1, wherein: the addition ratio of the vegetable fat powder is preferably such that the weight ratio of linoleic acid to alpha-linolenic acid in the final product is in the range of (5:1) - (15: 1).
7. The liquid infant milk according to claim 1 or 6, wherein: the vegetable fat powder comprises: the natural soybean oil and the corn oil clear are produced by refining, evaporating, concentrating and spray drying, the content of unsaturated fatty acid is more than or equal to 50 percent, and the thermal stability is good.
8. The liquid infant milk according to claim 1, wherein: the carbohydrate is lactose or oligosaccharide, preferably the oligosaccharide is: malto-oligosaccharide, isomaltooligosaccharide, raffinose (consisting of glucose, fructose and galactose), stachyose (consisting of trisaccharide constituting raffinose plus one galactose), soybean oligosaccharide (a-galactosides, mainly consisting of stachyose tetrasaccharide, raffinose, Vabasose and the like, which are commercially available), lactose and chicory plants.
9. The liquid infant milk according to any one of claims 1 to 8, wherein: the weight ratio of the compound vitamins in the infant liquid milk is as follows: vitamin A1375.3-5394.6 IU, vitamin D3252-884IU, 3-35.3U of vitamin E, 62.5-442mg of vitamin C, 25-191.8 mu g of vitamin K and vitamin B1350-2350-3510.5 μ g, vitamin B6212.5-1327.5 μ g, vitamin B120.625-10.6 mu g, 1.75-11.06mg nicotinic acid, 14100 mu g pantothenic acid 2375, 62.5-354 mu g folic acid and 10-70.8 mu g biotin.
10. The liquid infant milk according to claim 1, wherein: the composite mineral substance in the infant liquid milk is one or a combination of a plurality of the following components in percentage by weight: 350-1302.5mg of calcium, 708mg of phosphorus 150-19 mg, 30-106.2mg of magnesium, 350-1268.5mg of potassium, 1.8-38.4mg of iron, 3-10.6mg of zinc, 413mg of sodium 125-40 μ g of iodine, 210-855.5 μ g of copper and 6.25-734.5 μ g of manganese;
preferably, the added minerals are iron, zinc, calcium, magnesium, iodine, manganese and copper sources:
the iron is provided by one or more iron preparations such as ferrous gluconate, ferrous sulfate, ferrous lactate, ferric citrate, ferric pyrophosphate, etc.;
the zinc is provided by one or a combination of zinc preparations such as zinc sulfate, zinc gluconate, zinc lactate, zinc chloride and the like;
the calcium is provided by one or more calcium preparations such as milk calcium, calcium citrate, calcium phosphate, calcium chloride, calcium carbonate, calcium lactate, etc.;
the magnesium is provided by one or more magnesium preparations such as magnesium sulfate, magnesium chloride, magnesium citrate, etc.;
iodine is provided by potassium iodide;
manganese is provided by manganese sulfate;
the copper is provided by copper sulfate.
11. Liquid milk according to claim 1, characterized in that: the emulsion stabilizer is selected from: two or more of phospholipid, carrageenan, guar gum, locust bean gum, mono/di/tri fatty acid glyceride, monoglyceride and sucrose ester; the addition amount is 0.01-0.6% by weight; the preferred range is 0.1% -0.4%; wherein, the preferred combination of carrageenan (the addition amount is 0.01-0.05% by weight), locust bean gum (the addition amount is 0.02-0.08% by weight), and mono/di/triglyceride (the addition amount is 0.02-0.08% by weight); or preferably guar gum (added in an amount of 0.05-0.1 wt%), mono/di/triglyceride (added in an amount of 0.02-0.05 wt%), and mono-dry ester (added in an amount of 0.02-0.05 wt%); or preferably phospholipid (added in an amount of 0.05-0.1 wt%), mono/di/triglyceride (added in an amount of 0.02-0.05 wt%), and sucrose ester (added in an amount of 0.05-0.1 wt%).
12. Liquid milk according to claim 1, characterized in that: the algae DHA is selected from: from natural sources, whole plant sources are the most readily digestible triglyceride form by humans (as is DHA form in breast milk); without any substances present in too high a quantity, such as phospholipids and cholesterol; the marine pollutants and toxic substances possibly existing in the fish oil are not contained; has excellent bioavailability for infants. Wherein the DHA is embedded with a stabilizing material before use, and when the DHA is added, AA is also added, preferably the weight of the AA is 1.9 times that of the DHA, wherein the more preferable weight ratio of the AA to the DHA is 1.8-2.3: 1, and the preferable coating material for embedding the DHA is as follows: modified starch and maltodextrin.
13. The method for preparing liquid infant milk according to any one of claims 1-12, wherein: the method comprises the following steps:
(1) checking and accepting raw milk; (2) pretreating raw milk; (3) preparing materials; (4) preheating and homogenizing; (5) sterilizing; (6) cooling; (7) sterile addition; (8) sterile filling and obtaining finished products;
wherein, the sterile adding method in the step (7) comprises the following steps: for the heat-sensitive nutritional components, an online adding process is selected, the heat-sensitive components are stored in a sterile bag or a sterile tank in a liquid sterile state, a sterile adding system is connected, and the heat-sensitive components are added into the sterile tank or quantitatively added into a pipeline.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2008101835154A CN101427796A (en) | 2008-07-09 | 2008-12-17 | Liquid milk with additive algae docosatetraenoic acid suitable for baby of 0 to 6 months old |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200810133192.8 | 2008-07-09 | ||
| CNA2008101331928A CN101313716A (en) | 2008-07-09 | 2008-07-09 | Liquid milk with additive vitamin suitable for baby of birth time to 6 months ages |
| CNA2008101835154A CN101427796A (en) | 2008-07-09 | 2008-12-17 | Liquid milk with additive algae docosatetraenoic acid suitable for baby of 0 to 6 months old |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101427796A true CN101427796A (en) | 2009-05-13 |
Family
ID=40104972
Family Applications (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2008101331928A Pending CN101313716A (en) | 2008-07-09 | 2008-07-09 | Liquid milk with additive vitamin suitable for baby of birth time to 6 months ages |
| CNA2008101835154A Pending CN101427796A (en) | 2008-07-09 | 2008-12-17 | Liquid milk with additive algae docosatetraenoic acid suitable for baby of 0 to 6 months old |
| CNA2008101835192A Pending CN101427800A (en) | 2008-07-09 | 2008-12-17 | Liquid milk with additive oligose suitable for baby of 0 to 6 months old |
| CNA2008101835173A Pending CN101427798A (en) | 2008-07-09 | 2008-12-17 | Liquid milk with additive nucleotide suitable for baby of 0 to 6 months old |
| CNA2008101835188A Pending CN101427799A (en) | 2008-07-09 | 2008-12-17 | Liquid milk with additive taurine suitable for baby of 0 to 6 months old |
| CNA2008101835169A Pending CN101427797A (en) | 2008-07-09 | 2008-12-17 | Liquid milk with additive arachidonic acid suitable for baby of 0 to 6 months old |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2008101331928A Pending CN101313716A (en) | 2008-07-09 | 2008-07-09 | Liquid milk with additive vitamin suitable for baby of birth time to 6 months ages |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2008101835192A Pending CN101427800A (en) | 2008-07-09 | 2008-12-17 | Liquid milk with additive oligose suitable for baby of 0 to 6 months old |
| CNA2008101835173A Pending CN101427798A (en) | 2008-07-09 | 2008-12-17 | Liquid milk with additive nucleotide suitable for baby of 0 to 6 months old |
| CNA2008101835188A Pending CN101427799A (en) | 2008-07-09 | 2008-12-17 | Liquid milk with additive taurine suitable for baby of 0 to 6 months old |
| CNA2008101835169A Pending CN101427797A (en) | 2008-07-09 | 2008-12-17 | Liquid milk with additive arachidonic acid suitable for baby of 0 to 6 months old |
Country Status (1)
| Country | Link |
|---|---|
| CN (6) | CN101313716A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104171000A (en) * | 2014-07-07 | 2014-12-03 | 天添爱(青岛)生物科技有限公司 | Complementary food nutritional bag for infants and children and preparation method thereof |
| CN114794238A (en) * | 2021-01-29 | 2022-07-29 | 黑龙江飞鹤乳业有限公司 | Infant formula liquid milk and preparation method thereof |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101816334B (en) * | 2010-01-29 | 2012-07-18 | 李晓林 | Defatted and desugared milk powder with hypoglycemic effect and preparation method thereof |
| CN103155999B (en) * | 2011-12-16 | 2015-08-26 | 光明乳业股份有限公司 | A kind of nutrient modularization baby milk powder and feedstock composition thereof |
| CN102613300A (en) * | 2012-04-24 | 2012-08-01 | 澳优乳业（中国）有限公司 | Infant formula milk powder for preventing diarrhea and preparation method thereof |
| CN102630760B (en) * | 2012-05-11 | 2013-07-17 | 光明乳业股份有限公司 | Infant formula concentrated milk and preparation method thereof |
| CN102715239A (en) * | 2012-07-09 | 2012-10-10 | 澳优乳业（中国）有限公司 | Small peptide high-protein milk powder for children and preparation method thereof |
| CN102960615A (en) * | 2012-12-25 | 2013-03-13 | 江西德上科技药业有限公司 | Organic rice powder capable of increasing infant bone mineral density |
| CN113171331B (en) * | 2021-05-14 | 2021-12-10 | 广州锦同生物科技有限公司 | Ice crystal amino acid shower gel and preparation method thereof |
| CN115669730A (en) * | 2022-10-31 | 2023-02-03 | 黑龙江辰鹰乳业有限公司 | Formula liquid milk suitable for 0-6 month babies and preparation method thereof |
-
2008
- 2008-07-09 CN CNA2008101331928A patent/CN101313716A/en active Pending
- 2008-12-17 CN CNA2008101835154A patent/CN101427796A/en active Pending
- 2008-12-17 CN CNA2008101835192A patent/CN101427800A/en active Pending
- 2008-12-17 CN CNA2008101835173A patent/CN101427798A/en active Pending
- 2008-12-17 CN CNA2008101835188A patent/CN101427799A/en active Pending
- 2008-12-17 CN CNA2008101835169A patent/CN101427797A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104171000A (en) * | 2014-07-07 | 2014-12-03 | 天添爱(青岛)生物科技有限公司 | Complementary food nutritional bag for infants and children and preparation method thereof |
| CN114794238A (en) * | 2021-01-29 | 2022-07-29 | 黑龙江飞鹤乳业有限公司 | Infant formula liquid milk and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101427799A (en) | 2009-05-13 |
| CN101313716A (en) | 2008-12-03 |
| CN101427800A (en) | 2009-05-13 |
| CN101427798A (en) | 2009-05-13 |
| CN101427797A (en) | 2009-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101427796A (en) | Liquid milk with additive algae docosatetraenoic acid suitable for baby of 0 to 6 months old | |
| CN101233876B (en) | Low lactose liquid state milk suitable for baby from 0 to 12 months old | |
| CN101427791A (en) | Liquid milk with additive algae docosatetraenoic acid suitable for baby of 6 to 12 months old | |
| CN101427786A (en) | Liquid state milk with additive algae DHA suitable for baby from 12 to 36 months old | |
| CN102550677A (en) | Liquid dairy product with health-care function on middle and old-aged people and production method for liquid dairy product | |
| CN101313721B (en) | Liquid milk with additive serum albumin suitable for baby of birth time to 6 months ages | |
| CN101313702B (en) | Liquid milk for baby of 6 to 12 months ages and preparation method with ejection type direct disinfection | |
| CN101313704A (en) | Liquid milk for baby of birth time to 12 months ages and method using online addition technique | |
| CN101313700B (en) | Liquid milk for baby of 6 to 12 months ages and preparation method of injection type direct disinfection | |
| CN101317597B (en) | Liquid milk for baby of birth to 6 months age and preparation method of spray type direct disinfection | |
| CN101218941B (en) | Mineral matter element added liquid condition milk for baby | |
| CN101218942B (en) | Serum albumin added liquid condition milk for baby | |
| CN101313699B (en) | Liquid milk for baby of 12 to 36 months ages and preparation method for injection type direct disinfection | |
| CN101317609B (en) | Liquid milk with additive serum albumin for baby of 6 to 12 months age | |
| CN101317596B (en) | Liquid milk for baby of 12 to 36 months age and method for using on-line addition technique thereof | |
| CN101317598B (en) | Liquid milk for baby of zero to 6 months age and preparation using injection type direct disinfection | |
| CN101313703B (en) | Liquid milk for baby of 12 to 36 months age and preparation method with ejection type direct disinfection | |
| CN101233875B (en) | Liquid state milk suitable for baby from 6 to 12 months old | |
| CN102511558B (en) | Liquid milk applicable to babies 6-12 months old and production method of liquid milk | |
| CN101313701B (en) | Liquid milk for baby of 6 to 12 months age | |
| CN101317608B (en) | Liquid milk with additive serum albumin for baby of 12 to 36 months age | |
| CN101317602B (en) | Liquid milk with additive plant fat for baby of birth to 6 months age | |
| KR101752197B1 (en) | Manufacturing method of infant formula containing vegetable docosahexaenoic acid | |
| CN108935706A (en) | A kind of nutrition is comprehensive and the babies ' formula milk powder and preparation method thereof of absorption easy to digest |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20090513 |